
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Human Cancer Biology |
Authors' Affiliations: 1 Department of Pathology and Laboratory Medicine, 2 Division of Hematology/Oncology, Children's Memorial Hospital, and 3 The Department of Preventative Medicine, Northwestern University Feinberg School of Medicine, and the Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois
Requests for reprints: Elizabeth J. Perlman, Children's Memorial Hospital, 2300 Children's Plaza, Box 17, Chicago, IL 60614. Phone: 773-880-4306; Fax: 773-880-3858; E-mail: eperlman{at}childrensmemorial.org.
Purpose and Experimental Design: Clear cell sarcoma of the kidney (CCSK), the second most common renal tumor in children, poses significant diagnostic challenges. No positive diagnostic markers are available, and the pathogenesis of CCSK remains an enigma. To address these challenges, the gene expression patterns of 14 CCSKs were compared with 15 Wilms tumors and 3 fetal kidney samples using oligonucleotide arrays.
Results: Using unsupervised methods, the gene expression profile of CCSK was distinctive: differentially expressed genes could largely be grouped into four categories: (a) a wide variety of neural markers, (b) members of the Sonic hedgehog pathway, (c) members of the phosphoinositide-3-kinase/Akt cell proliferation pathway, and (d) known therapeutic targets. Corresponding changes in critical proteins using Western blot and/or immunohistochemistry confirmed the up-regulation of these pathways and proteins. In particular, CD117 and epidermal growth factor receptor are up-regulated at the protein level in many CCSKs, providing potential therapeutic targets. One of the neural markers, nerve growth factor receptor, represents a promising diagnostic tool for CCSK.
Conclusions: This study suggests that CCSKs arise within a renal mesenchymal cell that shows a wide variety of neural markers. As such, it seems to be susceptible to genetic changes also seen in a variety of other neuroectodermal and neuronal tumors, including activation of Sonic hedgehog and phosphoinositide-3-kinase/Akt pathways. Involvement of these pathways in CCSKs implicates their widening role in tumorigenesis.
This article has been cited by other articles:
![]() |
C. Jones, M. Rodriguez-Pinilla, M. Lambros, D. Bax, B. Messahel, G. M Vujanic, J. S Reis-Filho, and K. Pritchard-Jones c-KIT overexpression, without gene amplification and mutation, in paediatric renal tumours J. Clin. Pathol., November 1, 2007; 60(11): 1226 - 1231. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-C. Link, U. Reichelt, M. Schreiber, J. T. Kaifi, R. Wachowiak, D. Bogoevski, M. Bubenheim, G. Cataldegirmen, K. A. Gawad, R. Issa, et al. Prognostic Implications of Netrin-1 Expression and Its Receptors in Patients with Adenocarcinoma of the Pancreas Ann. Surg. Oncol., September 1, 2007; 14(9): 2591 - 2599. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Little, D. A. Bax, M. Rodriguez-Pinilla, R. Natrajan, B. Messahel, K. Pritchard-Jones, G. M. Vujanic, J. S. Reis-Filho, and C. Jones Multifaceted Dysregulation of the Epidermal Growth Factor Receptor Pathway in Clear Cell Sarcoma of the Kidney Clin. Cancer Res., August 1, 2007; 13(15): 4360 - 4364. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |